These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1458579)

  • 1. Fluorescence polarization immunoassay and HPLC assays compared for measuring monoethylglycinexylidide in liver-transplant patients.
    Chen Y; Potter JM
    Clin Chem; 1992 Dec; 38(12):2426-30. PubMed ID: 1458579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of monoethylglycinexylidide by fluorescence polarization immunoassay in highly icteric serum samples: modified precipitation procedure and HPLC compared.
    Schütz E; Shipkova M; Niedmann PD; Wieland E; Armstrong VW; Oellerich M
    Clin Chem; 1998 Jun; 44(6 Pt 1):1269-74. PubMed ID: 9625052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The monoethylglycinexylidide test does not correctly evaluate lidocaine metabolism after ischemic liver injury in the rat.
    Leclercq I; Saliez A; Wallemacq PE; Horsmans Y; Lambotte L
    Hepatology; 1997 Nov; 26(5):1182-8. PubMed ID: 9362360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoethylglycinexylidide formation kinetics: a novel approach to assessment of liver function.
    Oellerich M; Raude E; Burdelski M; Schulz M; Schmidt FW; Ringe B; Lamesch P; Pichlmayr R; Raith H; Scheruhn M
    J Clin Chem Clin Biochem; 1987 Dec; 25(12):845-53. PubMed ID: 3443824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quick, sensitive high-performance liquid chromatography assay for monoethylglycinexylidide and lignocaine in serum/plasma using solid-phase extraction.
    Chen Y; Potter JM; Ravenscroft PJ
    Ther Drug Monit; 1992 Aug; 14(4):317-21. PubMed ID: 1519306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of monoethylglycinexylidide as a liver function test in the liver transplant recipient.
    Potter JM; Hickman PE; Lynch SV; Henderson A; Wright M; Balderson G; Strong RW
    Transplantation; 1993 Dec; 56(6):1385-8. PubMed ID: 8279008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of an extended monoethylglycinexylidide formation test and other dynamic liver function tests in liver transplant donors.
    Zotz RB; von Schönfeld J; Erhard J; Breuer N; Lange R; Beste M; Goebell H; Eigler FW
    Transplantation; 1997 Feb; 63(4):538-41. PubMed ID: 9047147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MEGX test: a tool for the real-time assessment of hepatic function.
    Oellerich M; Armstrong VW
    Ther Drug Monit; 2001 Apr; 23(2):81-92. PubMed ID: 11294522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
    Kupcová V; Turecký L; Szántová M; Schmidtová K
    Bratisl Lek Listy; 1999 Jan; 100(1):12-24. PubMed ID: 10492993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of age on plasma MEGX concentrations.
    Orlando R; Palatini P
    Br J Clin Pharmacol; 1997 Aug; 44(2):206-8. PubMed ID: 9278213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the monoethylglycinexylidide test in pediatric liver transplant candidates.
    Burdelski M; Schütz E; Nolte-Buchholtz S; Armstrong VW; Oellerich M
    Ther Drug Monit; 1996 Aug; 18(4):378-82. PubMed ID: 8857554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of the lidocaine-monoethylglycinexylidide test in the liver transplant recipient.
    Potter JM; Hickman PE; Henderson A; Balderson GA; Lynch SV; Strong RW
    Ther Drug Monit; 1996 Aug; 18(4):383-7. PubMed ID: 8857555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of gender on the monoethylglycinexylidide test in normal subjects and liver donors.
    Oellerich M; Schütz E; Polzien F; Ringe B; Armstrong VW; Hartmann H; Burdelski M
    Ther Drug Monit; 1994 Jun; 16(3):225-31. PubMed ID: 8085276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unreliability of the lidocaine/monoethylglycinexylidide test for assessment of liver donors.
    Reding R; Wallemacq P; de Ville de Goyet J; Lerut J; Hausleithner V; Feyaerts A; Lambotte L; Otte JB
    Transplantation; 1993 Aug; 56(2):323-6. PubMed ID: 8356585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrahepatic production of the lignocaine metabolite monoethylglycinexylidide (MEGX).
    Sallie RW; Tredger JM; Williams R
    Biopharm Drug Dispos; 1992 Oct; 13(7):555-8. PubMed ID: 1489946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a fluorescence polarization immunoassay for teicoplanin in serum.
    Mastin SH; Buck RL; Mueggler PA
    Diagn Microbiol Infect Dis; 1993 Jan; 16(1):17-24. PubMed ID: 8425374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lignocaine metabolite formation as a measure of pre-transplant liver function.
    Oellerich M; Burdelski M; Ringe B; Lamesch P; Gubernatis G; Bunzendahl H; Pichlmayr R; Herrmann H
    Lancet; 1989 Mar; 1(8639):640-2. PubMed ID: 2564460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine determinations in heart and liver transplant recipients: comparison of HPLC and FPIA methods on whole blood and plasma.
    Corda C; Escousse A; Santona L; Guédon F; Mounié J
    Therapie; 1991; 46(2):115-7. PubMed ID: 2053089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of cyclosporine by liquid chromatography and three immunoassays in blood from liver, cardiac, and renal transplant recipients.
    McBride JH; Kim SS; Rodgerson DO; Reyes AF; Ota MK
    Clin Chem; 1992 Nov; 38(11):2300-6. PubMed ID: 1424128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic method for the simultaneous determination of monoethylglycinexylidide and lignocaine.
    Chen Y; Potter JM; Ravenscroft PJ
    J Chromatogr; 1992 Feb; 574(2):361-4. PubMed ID: 1618973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.